ArticleMolecular oncology2020

Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.

Qian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.